GLP-1

Category
peptide
Routes
Oral (PO)
Half-Life (t½)
PO: 2m
Formula
C149H226N40O45
Molecular Weight
3297.6 g/mol
PubChem CID
16133831
Aliases
Glucagon-like peptide-1, GLP-1(7-36), GLP-1(7-37)

Pharmacological Mechanism

Post-translational cleavage product of proglucagon, released from intestinal L cells in response to nutrient sensing. Activates GLP-1R on pancreatic β-cells (glucose-dependent insulin release), α-cells (glucagon suppression), hypothalamus (satiety), and gastric smooth muscle (slowed emptying). Rapidly inactivated by DPP-4 cleavage at the N-terminus — hence all clinical GLP-1 analogs carry Aib or other DPP-4-resistant substitutions.

Half-Life & Elimination Curve (PO: 2m)

100%50%25%12.5%0%0h0×t½2m1×t½5m2×t½7m3×t½9m4×t½11m5×t½0×t½ (0h): 100% remaining1×t½ (2m): 50% remaining2×t½ (5m): 25% remaining3×t½ (7m): 12.5% remaining4×t½ (9m): 6.3% remaining5×t½ (11m): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½2m50%
  • 2×t½5m25%
  • 3×t½7m12.5%
  • 4×t½9m6.3%
  • 5×t½11m3.1%
Elimination t½2m (PO)
Rate Constant (ke)18.2 h⁻¹
Clearance (CL)128 L/h
97% Washout (5×t½)11m

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References